| Jill Brown, MD | |
|
2301 S Lamar Blvd, Oxford, MS 38655-5373 | |
| (800) 291-4020 | |
| (919) 419-7247 |
| Full Name | Jill Brown |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 2301 S Lamar Blvd, Oxford, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154377950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2014039432 (Missouri) | Secondary |
| 207P00000X | Emergency Medicine | 18580 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Regional Medical Center | Kirksville, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ripley Emergency Group Llc | 1254757446 | 25 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Millions of you combine your passion for walking, running and cycling into a fun weekend of activity to benefit charitable causes. You pay your registration fee for the "athon," train and are asked to raise funds.
Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar survival trends between privately insured children and those with Medicaid at diagnosis, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis.
› Verified 5 days ago
| Entity Name | Bridgeton Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053660076 PECOS PAC ID: 5193978948 Enrollment ID: O20130104000140 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Millions of you combine your passion for walking, running and cycling into a fun weekend of activity to benefit charitable causes. You pay your registration fee for the "athon," train and are asked to raise funds.
Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar survival trends between privately insured children and those with Medicaid at diagnosis, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis.
› Verified 5 days ago
| Entity Name | Fenton Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770832792 PECOS PAC ID: 4789837923 Enrollment ID: O20130121000081 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Millions of you combine your passion for walking, running and cycling into a fun weekend of activity to benefit charitable causes. You pay your registration fee for the "athon," train and are asked to raise funds.
Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar survival trends between privately insured children and those with Medicaid at diagnosis, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis.
› Verified 5 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619332046 PECOS PAC ID: 6608056171 Enrollment ID: O20150312000325 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Millions of you combine your passion for walking, running and cycling into a fun weekend of activity to benefit charitable causes. You pay your registration fee for the "athon," train and are asked to raise funds.
Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar survival trends between privately insured children and those with Medicaid at diagnosis, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis.
› Verified 5 days ago
| Entity Name | Ripley Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720606023 PECOS PAC ID: 1254757446 Enrollment ID: O20200819000175 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Millions of you combine your passion for walking, running and cycling into a fun weekend of activity to benefit charitable causes. You pay your registration fee for the "athon," train and are asked to raise funds.
Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar survival trends between privately insured children and those with Medicaid at diagnosis, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill Brown, MD 3211 Shannon Rd, Suite 300, Durham, NC 27707-6322 Ph: (800) 291-4020 | Jill Brown, MD 2301 S Lamar Blvd, Oxford, MS 38655-5373 Ph: (800) 291-4020 |
News Archive
LightLab Imaging, Inc., pioneer and leader in the development of Optical Coherence Tomography (OCT) for coronary artery applications, today reported that Trial Judge Margaret Hinkle has set March 22 for the commencement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc.
Millions of you combine your passion for walking, running and cycling into a fun weekend of activity to benefit charitable causes. You pay your registration fee for the "athon," train and are asked to raise funds.
Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability.
Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.
A new study examines whether insurance status may affect survival in children diagnosed with cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest largely similar survival trends between privately insured children and those with Medicaid at diagnosis, with slight evidence for an increased risk of cancer death in children who were uninsured at diagnosis.
› Verified 5 days ago
Lane Lloyd Hartt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2301 S Lamar Blvd, Oxford, MS 38655 Phone: 800-291-4020 Fax: 919-419-7247 | |
Dr. Michael Jeffery Magee Ii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Belk Blvd, Oxford, MS 38655 Phone: 662-636-1000 | |
Thomas Glasgow, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2161 S Lamar Blvd, Oxford, MS 38655 Phone: 662-234-1791 Fax: 662-234-4790 | |
John C. Allen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 504 Azalea Dr Ste A, Oxford, MS 38655 Phone: 662-236-7738 Fax: 662-236-9642 | |
Dr. Thomas D Fowlkes, M. D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1916 University Ave, Oxford, MS 38655 Phone: 662-281-1306 Fax: 662-281-1326 | |
Patrick Louis Carr, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Belk Blvd, Oxford, MS 38655 Phone: 662-232-8100 |